Hayvan Sağlığı Araştırmaları 2009 Yılı Program - Tagem

1. Doel, T. R., Collen, T. (1982): Qualitative assessment of 146S particles of FMDV in preparations
destined for vaccines. J. Biol. Stand.. 10, 69-81.
2. Fenner, F., Bachmann, P.A., Gibbs, E.P.J., Murphy, F.A., Studert, M.J. and White, D.O.
(1987): Veterinary Virology. Academic Press Inc., London. 2. Anderson, E. C., Doughty, W. J.,
Muthiani, A., (1983): Observations on the stability of foot and mouth disease vaccine antigens. Vaccine
Dec.1(1),26-30.
3. Thevasagayam, S. J. (1996). Molecular and serological characterisation of South African Territory
(SAT) serotypes of foot-and-mouth disease virus (FMDV). PhD thesis, University of Hertfordshire,
UK.
4. Crowther J. R. (1986) Antigenic structure of foot and mouth disease virus.Rev.Sci.Tech. of Int.
Epiz. 5(2) : 299-314
5. Brown, F. (1985). Vaccination against foot-and-mouth disease: past, present and future. Annals
Institut Pasteur 136E, 547 552.
6. Rueckert RR (1990) Picornavirus and their multiplication. In: Fields BN, Knipe DM (eds)
Virology, 2nd edn. Raven Press, New York, pp 507-548
7. Brown F. (1992) New approaches to vaccination against foot-andmouth disease.
Vaccine;10(14):1022-1026.
8. Kitching R. P., Knowles N.J., Samuel A. R. and Donaldson A.I. (1989) Development of footand-mouth
disease virus strain characterisation. Tr0p. Anim. Hlth. Prod. 21, 153-166
9. Acharya R., Fry E., Stuart D., Fox G., Rowlands D. and Brown F. (1990), The structure of footand-mouth
disease virus: implications for its physical and biological properties, Vet. Microbiol. 23, pp.
21–34
10. Donaldson A. I. (1989) Standardization of diagnostic methods for foot and mouth disease . 11 th
International symposium of the world association of veterinary microbiologists, immunologists and
specialist in infectious disease. Venue,Italy
11.Mackay D.K.J., Rendle T., Kitching R.P. (1998).FAO collaborative study Phase XV:
standardisation of FMD antibody detection. In Report of the Session of the Research Group of the
Standing Technical Committee of the European Commission for the control of foot and mouth disease,
14-18 September, Aldershot, UK. FAO, Rome, 148-158.
12. Gürhan S. I. (1989). ����������������������������������������������������-106
13. Barteling S. J. ( 2002) Development and performance of inactivated vaccines against foot and
mouth disease. Rev. Sci. Tech Off Epiz. 21 (3): 577-588
14. Wild, T. F., Burroughs, J.N., Brown, F. (1969). Surface structure of foot- and -mouth disease virus.
J. Gen. Virol. 4: 313����
15. Burroughs J. N., Rowlands D. J., Sangar D.V., Talbot P., Brown F. (1971) Further evidence for
multiple proteins in the foot-and-mouth disease virus particle. Journal of General Virology 13, 73-84
16. Anderson, E. C., Doughty, W. J., Muthiani, A. (1983): Observations on the stability of foot and
mouth disease vaccine antigens. Vaccine Dec. 1(1),26-30.
17. Doel, T.R., Pullen, L. (1990): International bank for foot-and-mouth disease vaccine: stability
studies with virus J. Biol. Stand. 10, 185-195
18. Barteling, S.J., Cassim, N.I. (2000): Formaldehyde enhances BEI-inactivation rates of foot-andmouth
disease (FMD) virus by at least a ten-fold, In: Report ; European Commission for the Control of
Foot-and-Mouth Disease. Research Group of the Standing Technical Committee, Borovets (Bulgaria), /
FAO, Rome (Italy). Animal Production and Health Div., 270-275
14. ����������YI
����������� Tarih ����
14.1.Proje Lideri ������������������ 23.02.2009
��������������������������� : Dr. Recep ERGÜL
���������������������������� :
���������������������������������� :
149